首页> 外国专利> Dna Oligomer, Genetic Marker and Dna Oligomer Set for Prediction of Onset of Side-Effect from Radiation Therapy, and Method for Predicting Onset of Side-Effect

Dna Oligomer, Genetic Marker and Dna Oligomer Set for Prediction of Onset of Side-Effect from Radiation Therapy, and Method for Predicting Onset of Side-Effect

机译:用于预测放射治疗副作用发作的Dna低聚物,遗传标记和Dna低聚物集,以及用于预测副作用发作的方法

摘要

There are provided a DNA oligomer, a genetic marker, and a DNA oligomer set (PCR primer set) and a DNA oligomer (extension primer) for predicting a possibility of onset of a side-effect from radiation therapy for cancer by determining whether a specific base in a DNA sequence is a risk allele or a non-risk allele, and a method for predicting onset of a side-effect from radiation therapy. The DNA oligomer for a prediction of onset of a side-effect from radiation therapy has a DNA sequence of at least 10-241 contiguous bases with a 121st base from a sequence of any one of SEQ ID NOs: 1-173 in the Sequence Listing.
机译:提供了DNA寡聚物,遗传标记以及DNA寡聚物组(PCR引物组)和DNA寡聚物(延伸引物),用于通过确定是否特异性地预测癌症的放射疗法产生副作用的可能性。 DNA序列中的碱基是风险等位基因或非风险等位基因,以及一种预测放射治疗副作用发作的方法。用于预测放射疗法的副作用发作的DNA低聚物具有至少10-241个连续碱基的DNA序列,该序列具有序列表中SEQ ID NO:1-173中任一项的121st个碱基。 。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号